Abstract
2311P Population pharmacokinetic-pharmacodynamic modeling to inform optimal dosing strategies for GI-101, a novel fusion protein, targeting IL2βγR and CTLA4
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have